alterations 11 . Hemodynamic and radionuclide studies (Burger et al. 1997 , Hirata 1992 have demonstrated long term improvement in RVF after Percutaneous balloon mitral valvuloplasty (PTMC). Few studies have examined the immediate impact of PTMC on echocardiographic markers of RV systolic and diastolic function 4, 7, 10 . There is no study showing midterm effect on right ventricular function following PTMC. The purpose of this study is to assess the immediate and midterm effect of PTMC on RVF using two and three dimensional, pulse and tissue Doppler echocardiographic indices.
However, systematic assessment of right ventricular function is not uniformly carried out in past due to enormous attention given to the evaluation of the left heart and paucity of ultrasound studies providing normal reference value of right ventricular function. It is hoped that this study will lead to further work in future over larger populations and application of the values will enhance the value of echocardiography in recognizing right ventricular function as well as improving disease detection and patient followup 25 .
Percutaneous valvotomy using inflatable balloon catheters was first developed as a therapeutic option for congenital pulmonary and aortic valvular stenosis almost 30 years ago. Percutaneous mitral balloon valvotomy has subsequently become a mainstay of the management of rheumatic mitral stenosis . In the past, closed or open commissurotomy (after the advent of cardiopulmonary bypass) was the mainstay of therapy for rheumatic mitral stenosis. However, in the early 1980s, several techniques of mitral balloon valvotomy were developed incorporating single or double cylindrical balloons, and even a mechanical dilator. Currently, this procedure is most often performed using trans septal access to the left atrium and a balloon catheter developed by a Japanese surgeon, Kanji Inoue.
There are few studies on immediate outcome of PTMC in patients with MS. There is also no study showing midterm effect on right ventricular function following PTMC. Because the availability, cost effectiveness and sensitivity of echocardiography in measurement of right ventricular function, the current study is done with an aim to identify some new parameters related to prognosis and outcome of PTMC in MS patients. 
Echocardiographic Measurements:
After selection of the study sample that fulfilled the inclusion criteria, two and three dimensional echocardiography and pulse and tissue Doppler studies was performed 24-72 hours before and 24 -48 hours and 6 -12 months after PTMC.
All study patients underwent an echocardiographic examination with the Vivid 7 Dimension ultrasound imaging system (General Electric, GE), which is equipped with a 3.5 MHz transducer for 2D-TTE, and a 4 MHz 4X matrix array transducer for 3D-TTE. The same experienced echo cardiographer performed all measurements using the recommendations of the American Society of Echocardiography Mitral valve area (MVA) was determined by planimetry in every patient. The Wilkins score was used to judge mitral leaflet mobility, valvular and subvalvular thickening, and calcification (Wilkins et al. 1998) . Twenty four to 48 h and 6 months after mitral balloon dilatation, MVA was again determined by planimetry. Systolic pulmonary artery pressure was derived from the tricuspid regurgitant jet peak velocity using the modified Bernoulli equation (peak gradient 4V 2 , where V is the maximal velocity of the tricuspid regurgitant jet). We further assumed a right atrial mean pressure of 10 mmHg in patients, based on the absence of inferior vena cava dilation greater than20 mm, and 5 mmHg in controls. From the parasternal short-axis view at the level of the aortic root, the RV outflow tract diameters at enddiastole and end-systole were measured. RV outflow tract fractional shortening (RVOTfs) was calculated using the formula RVOTfs = [RVOTd -RVOTs]/RVOTd where d and s represent enddiastolic and end-systolic dimensions.
The tricuspid annular plane systolic excursion (TAPSE) was determined by the difference in the displacement of the RV base during systole and diastole. TAPSE is acquired by placing an M-mode cursor through the tricuspid annulus and measuring the amount of longitudinal motion of the annulus at peak systole.
RV end-diastolic and end-systolic areas were measured from the apical four chamber view to calculate RV fractional area change (RVFAC). 
Fig.-3: Measurement of right ventricular outflow tract (RVOT) dimensions at the proximal or subvalvular level (RVOT-Prox) and at the distal or pulmonic valve (RVOT-Distal) in the (A) parasternal long-axis RVOT anterior portion view, (B) basal parasternal short-axis view.
taken from different images, and one must therefore attempt to use beats with similar R-R intervals to obtain a more accurate Tei index or RIMP value. We did not measure regional RV Tei index from DTI (Doppler tissue imaging). The disk summation method has also been applied to determine a RV ''body'' volume, using predominantly right ventricle-focused apical 4-chamber view. RV EF from 2D methods is calculated as (end-diastolic volume -end-systolic volume)/end-diastolic volume). 
Fig.-6: Calculation of right ventricular myocardial performance index (MPI) by pulsed Doppler and pulsed tissue Doppler [MPI = (TCO -ET)/ET]
with gains adjusted to eliminate transvalvular flow velocities and minimize noise. A 3.5 mm sample volume was placed at the septal and lateral side of the tricuspid annulus. Peak myocardial velocities during systole, early, and late diastole together with the isovolumic contraction time were measured at a sweep speed of 100 mm/s. Myocardial acceleration during isovolumic contraction (IVA) was measured by dividing myocardial velocity during isovolumic contraction by the time interval from onset of the myocardial velocity during isovolumic contraction to the time at peak velocity of this wave. RVS / or RV systolic excursion velocity measured by pulsed tissue Doppler. To perform this measure, an apical 4-chamber window is used with a tissue Doppler mode region of interest highlighting the RV free wall. The pulsed Doppler sample volume is placed in either the tricuspid annulus or the middle of the basal segment of the RV free wall. All 2D and 3D echocardiographic and Doppler studies were analyzed by 2 experienced readers by the average 5 cardiac cycles to minimize difference during the breath cycle (using the recommendation of the American society of echocardiography).
Statistical Analysis
expressed as mean ± SD. Analysis employed the ANOVA to determine the significance of differences before, immediate and 6 months after PTMC. The differences between patients with MS and healthy subjects were identified using an Student's t-test. A p value < 0.05 as considered statistically significant.
Results:
The findings of the study obtained from data analysis are presented below: Table I showing majorities (68%) of study population were in age group 36-40 years and 32% were in age group 30-35 years. The average age was 35.36 years. Regarding sex, majority were female (66%) and male (34%). In occupational status, 16% were businessmen, 34% were house wife and 50% were others. Table II demonstrates the clinical profile of the study population. 90% patients complained of fatigue, 85% presented with shortness of breath, palpitation in 65%, chest pain in 28%, ankle edema in 15%, headache among 10% and dizziness 25%. Table III showing echocardiographic measures of study population MVA significantly increased post PTMC were statistically significant (0.001).LVESD, LVEDD, LVEF and IVS remains stable which were statistically not significant. Table VI showing echocardiographic measurement of right heart dimension of study population. RA dimension (mm) and RVOT dimension(mm) decreased significantly post PTMC than pre PTMC which are statistically significant (0.001). RV wall thickness did not showed statistically significant improvement. Table VIII showing hemodynamic function of study population. This is significant improvement of haemodynamic function in immediate and 6 months after PTMC than pre PTMC. RA pressure, PASP, PADP and mean PAP decreased post PTMC which are statistically significant. 
E(cm/S), A(cm/S), E/A ratio &
Deceleration time showed improvement in immediate and 6 months after PTMC which were statistically significant (p=0.001). Table XIV showing 3D echocardiographic measure of RV function. RVEF increase 6 months and RV volume decrease both of these are statistically significant (p=0.001).
Discussion:
Mitral stenosis might cause impairment of right ventricular (RV) function due to both an increase in RV after load and rheumatic myocardial disease. Mitral valve disease is associated with proportional changes in right-sided heart morphology; however, severe tricuspid regurgitation is nearly always associated with right ventricular dysfunction, suggesting a synergistic relationship. Right ventricular dysfunction is likely as important as tricuspid regurgitation because it offers an explanation for the negative prognostic The quantitative echocardiographic assessment of RV function is difficult because of the ventricle's complex The mode of clinical presentation in this study shows, 90% patients complained of fatigue, shortness of breath in 85%, palpitation in 65%, chest pain in 28%, ankle edema in 15%, headache among 10% and dizziness in 25%. Another study Kundu et al. (2012) reported that the majority (80%) of the patients complained shortness of breath, followed by 64% with palpitation, 30% with cough, 24% with chest pain and 6% with hemoptysis which is consistent with our current study.
In the present study, before PTMC, MVA by planimetry was (0.68+0.13 cm 2 ) which improved significantly immediately after (1.61+0.10 cm 2 ) and 6 months after PTMC (1.60+0.12cm 2 ) (p= 0.001). LVEDD ,LVESD and LVEF remained stable.
RA and RVOT dimensions significantly decreased immediately and 6 months after PTMC (p=0.001) which is consistent with another study done by Drighil et al. (2008) . RV wall thickness remained unchanged following PTMC which was not significant (p= 0.175).
In this study, RA pressure, PASP, PADP and mean PAP significantly decreased immediately and 6 months after PTMC which is significant (p=0.001). These parameters are consistent with other studies done by Drighil et al. (2008) and Borges et al. (2006) and Kundu et al. (2012) .
The present study also shows, RVOTfs(%) increased after PTMC than before PTMC from 52±5.1 to 67±6.0 and 77±0.6.0 (p= < 0.001) which is comparable to study done by Drighil et RV diastolic function E(cm/s) , A(cm/s) and Deceleration time was significantly improve immediately and 6 months after PTMC than before PTMC.
3D echocardiographic study of RV function in our study shows, significantly improvement in RVEF% 6 months after PTMC than before PTMC which was 48.84+5.89%, 43.64+5.47% respectively (p=0.001) but remain unchanged immediate after PTMC (44.52+5.65%)
This study was done to find out the improvement of right ventricular function immediately and 6 months after PTMC. Our results suggest that patients with MS have depressed global and regional function compared with normal subjects. The reasons for this impaired function in MS due to passive increase of left atrial pressure and the reactive changes of pulmonary arteriolar vasculature, right ventricular after load may increase to values 25 to 30 fold above normal, leading to right ventricular overload and right ventricular failure. The rheumatic heart disease may directly involve the myocardium, thus impairing right ventricular function (Burger et al. 1993 ). Intramyocardial branches of coronary vessels were involved in a form of active rheumatic vasculitis or inactive lesions characterized by medial hypertrophy and replacement fibrosis to cause dysfunction (Malhotra et al.1987) .
Conclusion:
This study shows after PTMC the parameters of infundibular and global RV function as assessed by RVOTfs and Tei index showed significant improvement immediate and 6 months after whether TAPSE,RVFAC and RVEF(2D and 3D) remain stable immediately after but showed significant improvement 6 months after PTMC. Significant decrease in RV contractility as assessed by IVA was observed and may actually reflect the acute decrease in RV afterload with its consequence on contractile function of the RV. Further work using larger numbers of patients is needed to confirm these findings and to assess their utility in patient follow-up and management.
Study Limitations
• The sample size was small in number
• Observation was done only in hospital and no long term outcome was observed.
• Unavailability of 3D RV reconstruction software leading to underestimation of RV volume
